Platelet Function Assessment for Atherothrombotic Patients
Status:
Unknown status
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Background-Despite the pivotal pathogenic role of platelets in atherothrombosis has been
widely recognized, there is a striking lack of consensus regarding how to measure platelet
function and how to monitor the effects of various antiplatelet drugs. In view of the fact
that recurrent ischemic events occurred in 8.5% to 8.8% of patients treated with dual
antiplatelet drugs and there is significant inter-individual variability in platelet
reactivity, we believe that the importance of platelet function assessment and its clinical
implication should not be overlooked.